Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Granzyme A pseudogene 1 (GZMAP1) is a non-coding genomic locus classified as a pseudogene of the functional Granzyme A gene (GZMA). Pseudogenes such as GZMAP1 are genomic DNA sequences similar to normal genes but typically non-functional; they do not produce active proteins. Most available scientific and clinical information concerns Granzyme A, a serine protease involved in cytotoxic T cell function and cell death pathways[1], but GZMAP1 itself is not known to have protein-coding ability, therapeutic relevance, or established biological roles.\n- GZMAP1 should not be confused with Granzyme A (protein, GZMA gene), which is a subject of therapeutic and immunological research[1][2]. GZMAP1 does not encode this enzyme.\n- If information is required for the functional protein-coding Granzyme A (GZMA), a new query should be issued for that target specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Granzyme A pseudogene 1 (GZMAP1).